Literature DB >> 26633623

HIV: Cure by killing.

Douglas D Richman1.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 26633623     DOI: 10.1038/nature16321

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  10 in total

Review 1.  The challenge of finding a cure for HIV infection.

Authors:  Douglas D Richman; David M Margolis; Martin Delaney; Warner C Greene; Daria Hazuda; Roger J Pomerantz
Journal:  Science       Date:  2009-03-06       Impact factor: 47.728

2.  Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial.

Authors:  Thomas A Rasmussen; Martin Tolstrup; Christel R Brinkmann; Rikke Olesen; Christian Erikstrup; Ajantha Solomon; Anni Winckelmann; Sarah Palmer; Charles Dinarello; Maria Buzon; Mathias Lichterfeld; Sharon R Lewin; Lars Østergaard; Ole S Søgaard
Journal:  Lancet HIV       Date:  2014-09-15       Impact factor: 12.767

3.  Bispecific antibodies that mediate killing of cells infected with human immunodeficiency virus of any strain.

Authors:  J Berg; E Lötscher; K S Steimer; D J Capon; J Baenziger; H M Jäck; M Wabl
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

4.  Tumor regression in cancer patients by very low doses of a T cell-engaging antibody.

Authors:  Ralf Bargou; Eugen Leo; Gerhard Zugmaier; Matthias Klinger; Mariele Goebeler; Stefan Knop; Richard Noppeney; Andreas Viardot; Georg Hess; Martin Schuler; Hermann Einsele; Christian Brandl; Andreas Wolf; Petra Kirchinger; Petra Klappers; Margit Schmidt; Gert Riethmüller; Carsten Reinhardt; Patrick A Baeuerle; Peter Kufer
Journal:  Science       Date:  2008-08-15       Impact factor: 47.728

5.  Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells.

Authors:  Julia A M Sung; Joy Pickeral; Liqin Liu; Sherry A Stanfield-Oakley; Chia-Ying Kao Lam; Carolina Garrido; Justin Pollara; Celia LaBranche; Mattia Bonsignori; M Anthony Moody; Yinhua Yang; Robert Parks; Nancie Archin; Brigitte Allard; Jennifer Kirchherr; JoAnn D Kuruc; Cynthia L Gay; Myron S Cohen; Christina Ochsenbauer; Kelly Soderberg; Hua-Xin Liao; David Montefiori; Paul Moore; Syd Johnson; Scott Koenig; Barton F Haynes; Jeffrey L Nordstrom; David M Margolis; Guido Ferrari
Journal:  J Clin Invest       Date:  2015-09-28       Impact factor: 14.808

6.  Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations.

Authors:  Kai Deng; Mihaela Pertea; Anthony Rongvaux; Leyao Wang; Christine M Durand; Gabriel Ghiaur; Jun Lai; Holly L McHugh; Haiping Hao; Hao Zhang; Joseph B Margolick; Cagan Gurer; Andrew J Murphy; David M Valenzuela; George D Yancopoulos; Steven G Deeks; Till Strowig; Priti Kumar; Janet D Siliciano; Steven L Salzberg; Richard A Flavell; Liang Shan; Robert F Siliciano
Journal:  Nature       Date:  2015-01-07       Impact factor: 49.962

7.  Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy.

Authors:  Julian H Elliott; Fiona Wightman; Ajantha Solomon; Khader Ghneim; Jeffrey Ahlers; Mark J Cameron; Miranda Z Smith; Tim Spelman; James McMahon; Pushparaj Velayudham; Gregor Brown; Janine Roney; Jo Watson; Miles H Prince; Jennifer F Hoy; Nicolas Chomont; Rémi Fromentin; Francesco A Procopio; Joumana Zeidan; Sarah Palmer; Lina Odevall; Ricky W Johnstone; Ben P Martin; Elizabeth Sinclair; Steven G Deeks; Daria J Hazuda; Paul U Cameron; Rafick-Pierre Sékaly; Sharon R Lewin
Journal:  PLoS Pathog       Date:  2014-11-13       Impact factor: 6.823

8.  Activation and lysis of human CD4 cells latently infected with HIV-1.

Authors:  Amarendra Pegu; Mangaiarkarasi Asokan; Lan Wu; Keyun Wang; Jason Hataye; Joseph P Casazza; Xiaoti Guo; Wei Shi; Ivelin Georgiev; Tongqing Zhou; Xuejun Chen; Sijy O'Dell; John-Paul Todd; Peter D Kwong; Srinivas S Rao; Zhi-yong Yang; Richard A Koup; John R Mascola; Gary J Nabel
Journal:  Nat Commun       Date:  2015-10-20       Impact factor: 14.919

9.  Bispecific single chain molecules (Janusins) target cytotoxic lymphocytes on HIV infected cells.

Authors:  A Traunecker; A Lanzavecchia; K Karjalainen
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

10.  Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy.

Authors:  N M Archin; A L Liberty; A D Kashuba; S K Choudhary; J D Kuruc; A M Crooks; D C Parker; E M Anderson; M F Kearney; M C Strain; D D Richman; M G Hudgens; R J Bosch; J M Coffin; J J Eron; D J Hazuda; D M Margolis
Journal:  Nature       Date:  2012-07-25       Impact factor: 49.962

  10 in total
  2 in total

1.  HDAC inhibition induces HIV-1 protein and enables immune-based clearance following latency reversal.

Authors:  Guoxin Wu; Michael Swanson; Aarthi Talla; Donald Graham; Julie Strizki; Daniel Gorman; Richard Jo Barnard; Wade Blair; Ole S Søgaard; Martin Tolstrup; Lars Østergaard; Thomas A Rasmussen; Rafick-Pierre Sekaly; Nancie M Archin; David M Margolis; Daria J Hazuda; Bonnie J Howell
Journal:  JCI Insight       Date:  2017-08-17

2.  Redirection of Cord Blood T Cells and Natural Killer Cells for Elimination of Autologous HIV-1-Infected Target Cells Using Bispecific DART® Molecules.

Authors:  Justin Pollara; R Whitney Edwards; Shalini Jha; Chia-Ying Kao Lam; Liqin Liu; Gundo Diedrich; Jeffrey L Nordstrom; Tori Huffman; Joy A Pickeral; Thomas N Denny; Sallie R Permar; Guido Ferrari
Journal:  Front Immunol       Date:  2020-04-21       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.